Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meclin versus dimenhydrinate for acute vertigo and vestibular dizziness
RBR-3pyzt5Phase 3Not yet recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dimenhydrinate in vertigo (2 arms), sponsored by Federal University of São Paulo. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
dimenhydrinate
03
Conditions
vertigo
Beyond the preview
Go deeper on RBR-3pyzt5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3pyzt5.